Related Experiment Video
Updated: May 22, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
The activation mechanism of ACK1 (activated Cdc42-associated tyrosine kinase 1)
Qiong Lin1, Jian Wang, Chandra Childress
1School of Medical Sciences and Laboratory Medicine, Jiangsu University, Zhenjiang 212013, China. qlin1@geisinger.edu
Abstract:
ACK [activated Cdc42 (cell division cycle 42)-associated tyrosine kinase; also called TNK2 (tyrosine kinase, non-receptor, 2)] is activated in response to multiple cellular signals, including cell adhesion, growth factor receptors and heterotrimeric G-protein-coupled receptor signalling. However, the molecular mechanism underlying activation of ACK remains largely unclear. In the present study, we demonstrated that interaction of the SH3 (Src homology 3) domain with the EBD [EGFR (epidermal growth factor receptor)-binding domain] in ACK1 forms an auto-inhibition of the kinase activity. Release of this auto-inhibition is a key step for activation of ACK1. Mutation of the SH3 domain caused activation of ACK1, independent of cell adhesion, suggesting that cell adhesion-mediated activation of ACK1 is through releasing the auto-inhibition. A region at the N-terminus of ACK1 (Leu10-Leu14) is essential for cell adhesion-mediated activation. In the activation of ACK1 by EGFR signalling, Grb2 (growth-factor-receptor-bound protein 2) mediates the interaction of ACK1 with EGFR through binding to the EBD and activates ACK1 by releasing the auto-inhibition. Furthermore, we found that mutation of Ser445 to proline caused constitutive activation of ACK1. Taken together, our studies have revealed a novel molecular mechanism underlying activation of ACK1.
Insights
Activated Cdc42-associated tyrosine kinase (ACK1) auto-inhibition is released by interactions with its SH3 and EGFR-binding domains. This mechanism explains ACK1 activation by cell adhesion and growth factor signaling.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- Activated Cdc42-associated tyrosine kinase (ACK1), also known as TNK2, is activated by various cellular signals.
- The precise molecular mechanisms governing ACK1 activation have remained largely undetermined.
- Understanding ACK1 activation is crucial for deciphering its role in cellular processes.
Purpose of the Study:
- To elucidate the molecular mechanism underlying ACK1 activation.
- To investigate the role of the SH3 and EGFR-binding domains in ACK1 auto-inhibition and activation.
- To identify key regions and interactions involved in ACK1 activation by cell adhesion and EGFR signaling.
Main Methods:
- Investigated the interaction between ACK1's SH3 domain and its EGFR-binding domain (EBD).
- Utilized site-directed mutagenesis to study the effects of mutations on ACK1 activity.
- Examined the role of Grb2 in mediating ACK1 activation by EGFR signaling.
Main Results:
- The interaction between ACK1's SH3 domain and EBD results in auto-inhibition of kinase activity.
- Release of this auto-inhibition is essential for ACK1 activation.
- Cell adhesion and EGFR signaling activate ACK1 by releasing this auto-inhibition, with Grb2 mediating the latter.
Conclusions:
- A novel auto-inhibition mechanism involving the SH3 and EBD domains regulates ACK1 activity.
- ACK1 activation by cell adhesion and EGFR signaling occurs through the release of this auto-inhibition.
- Specific mutations, such as Ser445 to proline, can lead to constitutive ACK1 activation.
Related Concept Videos
MAPK Signaling Cascades
Receptor Tyrosine Kinases
cAMP-dependent Protein Kinase Pathways
Intracellular Signaling Affects Focal Adhesions
Some...
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade

